{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:15:36Z","timestamp":1789269336474,"version":"build-2803163510"},"reference-count":24,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cystic Fibrosis Foundation (CFF) through the 2024 Screening Improvement Program (SIP) Award for Optimizing the Diagnosis of Infants","award":["007978QI324"],"award-info":[{"award-number":["007978QI324"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Cystic fibrosis (CF) is an autosomal recessive genetic condition affecting nearly 1 in 4000 newborns. Early diagnosis and treatment have been shown to improve the care of individuals with CF, which is enhanced through newborn screening (NBS). The state of Florida has been performing CF NBS since 2007, and in 2022, Florida implemented enhanced next generation sequencing (NGS). The goal of this change was to identify individuals from under-represented racial and ethnic groups, who may have rare or de novo variants. NBS screening for CF involved a first tier with immunoreactive trypsinogen (IRT) \u2265 50 or the top 4% of daily specimens, whichever is lower, reflexing to a second tier. As of 2022, the second tier has evolved to an expanded sequence with an Agena 74-variant panel. Single variants would then reflex to the third tier utilizing NGS. NGS is able to confirm what is detected in second-tier testing, adding variants not included in the Agena panel, and refining the TG replications for Poly-T variants to determine pathogenicity of 5T results. When there is a variant of varying clinical consequence between the two databases, the most conservative classification is selected. Individuals with variants would then be referred to one of the contracted CF NBS referral centers for confirmatory sweat chloride testing (sweat). With implementation of NGS, referrals nearly tripled in 2022\u20132024, with 538 referrals in 2019; 485 in 2020; and 805 in 2021; followed by 1223 referrals made in 2022; 1146 in 2023; and 1294 in 2024. In 2022\u20132024, 71% of referrals to the contracted NBS CF referral centers were for single variant results, and no cases of CF were identified from these referrals. The number of CF cases remained about the same, ranging from 23 to 40 through the years 2019\u20132024. The number of CRMS\/CFSPID cases, however, tripled going from 10 to 12 in 2019\u20132022 to over 100 in 2024. The reason for this change seems to be related to complex heterozygous genetic variants as opposed to abnormal sweat. Implementation of NGS for CF in Florida led to a significant increase in the identification of CFTR variants which affected all aspects of the NBS CF process, from an increased workload on the NBS laboratory and follow-up staff, to an increase in referrals to the NBS CF referral centers. The majority of referrals were for single-variant results, which meant the infants had a very low likelihood of having CF. It is recommended that when an algorithm involving NGS is utilized, one should verify that there are appropriate processes for sweat, including the manner in which single-variant CF results are handled, avoiding unnecessary healthcare utilization.<\/jats:p>","DOI":"10.3390\/ijns11040094","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T16:13:03Z","timestamp":1760717583000},"page":"94","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Next-Generation Sequencing for Cystic Fibrosis: Florida Newborn Screening Experience"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1728-8359","authenticated-orcid":false,"given":"Deanna M.","family":"Green","sequence":"first","affiliation":[{"name":"Division of Pediatric Pulmonology and Cystic Fibrosis, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL 33701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0665-2463","authenticated-orcid":false,"given":"Jean","family":"Polasky","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology and Cystic Fibrosis, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL 33701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Weatherly","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Sleep Medicine, Orlando Health Arnold Palmer Hospital for Children, Orlando, FL 32806, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5712-7286","authenticated-orcid":false,"given":"Heather","family":"Stalker","sequence":"additional","affiliation":[{"name":"Division of Pediatric Genetics and Metabolism, University of Florida, Gainesville, FL 32608, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Coastal Genetic Services, St. Augustine, FL 32080, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Kushner","sequence":"additional","affiliation":[{"name":"Pulmonary and Sleep Center, Joe DiMaggio Children\u2019s Hospital, Hollywood, FL 33021, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Couluris","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, University of South Florida, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ryland","sequence":"additional","affiliation":[{"name":"Newborn Screening Laboratory, Florida Department of Health, Bureau of Public Health Laboratory, Jacksonville, FL 32202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iruvanti","family":"Sunitha","sequence":"additional","affiliation":[{"name":"Newborn Screening Laboratory, Florida Department of Health, Bureau of Public Health Laboratory, Jacksonville, FL 32202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Fong","sequence":"additional","affiliation":[{"name":"Newborn Screening Laboratory, Florida Department of Health, Bureau of Public Health Laboratory, Jacksonville, FL 32202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Crump","sequence":"additional","affiliation":[{"name":"Newborn Screening Follow-Up Program, Florida Department of Health, Tallahassee, FL 32399, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Reeves","sequence":"additional","affiliation":[{"name":"Newborn Screening Follow-Up Program, Florida Department of Health, Tallahassee, FL 32399, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Barnette","sequence":"additional","affiliation":[{"name":"Newborn Screening Follow-Up Program, Florida Department of Health, Tallahassee, FL 32399, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(79)90825-0","article-title":"Dried-blood spot screening for Cystic Fibrosis in the newborn","volume":"1","author":"Crossley","year":"1979","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Scotet, V., L\u2019Hostis, C., and Ferec, C. (2020). The changing epidemiology of cystic fibrosis: Incidence, survival and impact of the CFTR gene discovery. Genes, 11.","DOI":"10.3390\/genes11060589"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1164\/rccm.200303-434OC","article-title":"Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis","volume":"168","author":"Farrell","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpeds.2016.10.045","article-title":"Differences in outcomes between early and late diagnosis of cystic fibrosis in the newborn screening era","volume":"181","author":"Coffey","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1309\/LM80L3XIRBJUBNTH","article-title":"Kids in America: Newborn screening for cystic fibrosis","volume":"42","author":"Bender","year":"2011","journal-title":"Lab. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jmoldx.2015.07.005","article-title":"The spectrum of CFTR variants in nonwhite cystic fibrosis patients: Implications for molecular diagnostic testing","volume":"18","author":"Schrijver","year":"2016","journal-title":"J. Mol. Diagn."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.GIM.0000139503.22088.66","article-title":"CFTR mutation distribution among US Hispanic and African American individuals; evaluation in cystic fibrosis patients and carrier screening populations","volume":"6","author":"Sugarman","year":"2004","journal-title":"Genet. Med."},{"key":"ref_8","unstructured":"(2025, September 23). CFTR2.org (CFTR2 Variant List History|CFTR2): Clinical and Functional Translation of CFTR. Available online: https:\/\/cftr2.org."},{"key":"ref_9","unstructured":"ClinVar (2025, September 23). National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, USA, Available online: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jcf.2024.10.015","article-title":"Characterization of 223 infants with CFTR-Related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID) identified during the first three years of newborn screening via IRT-DNA-SEQ in New York State","volume":"24","author":"Sadeghi","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1002\/ppul.27155","article-title":"Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities","volume":"59","author":"McGarry","year":"2024","journal-title":"Pediatr. Pulmonol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jpeds.2016.09.066","article-title":"Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome and cystic fibrosis screen positive, inconclusive diagnosis","volume":"181","author":"Ren","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_13","unstructured":"gnomAD (2025, September 23). gnomAD Browser, Available online: https:\/\/gnomad.broadinstitute.org\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ppul.26253","article-title":"Refinement of newborn screening for cystic fibrosis with next generation sequencing","volume":"58","author":"Rock","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpeds.2007.03.002","article-title":"Diagnostic sweat testing: The Cystic Fibrosis Foundation guidelines","volume":"151","author":"LeGrys","year":"2007","journal-title":"J. Pediatr."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shenoy, A., Spyropoulos, D., Peeke, K., Smith, D., Cellucci, M., and Chidekel, A. (2020). Newborn Screening for Cystic Fibrosis: Infant and Laboratory Factors Affecting Successful Sweat Test Completion. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7010001"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1542\/peds.2004-0275","article-title":"Psychosocial risk associated with newborn screening for cystic fibrosis: Parents\u2019 experience while awaiting the sweat-test appointment","volume":"115","author":"Tluczek","year":"2005","journal-title":"Pediatrics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12687-023-00666-8","article-title":"Experiences of cystic fibrosis newborn screening and genetic counseling","volume":"14","author":"Foil","year":"2023","journal-title":"J. Community Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcf.2024.09.011","article-title":"Cystic fibrosis foundation position paper: Redefining the cystic fibrosis care team","volume":"23","author":"Brown","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2023064657","DOI":"10.1542\/peds.2023-064657","article-title":"Cystic Fibrosis Foundation Evidence-Based Guideline for the Management of CRMS\/CFSPID","volume":"153","author":"Green","year":"2024","journal-title":"Pediatrics"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wolfe, A.G., Gilley, S.P., Waldrop, S.W., Olson, C., Harding, E., Widmer, K., Gumer, L.B., Haemer, M., and Hoppe, J.E. (2023). Case Report: Cystic fibrosis with kwashiorkor: A rare presentation in the era of universal newborn screening. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.1083155"},{"key":"ref_22","first-page":"101572","article-title":"Five cases of missed cystic fibrosis heterozygous mutations identified after a positive newborn screen on a sibling","volume":"36","author":"Qussous","year":"2022","journal-title":"Respir. Med. Case Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1542\/peds.2010-0286","article-title":"The need for vigilance: The case of a false-negative newborn screen for cystic fibrosis","volume":"128","author":"Dunn","year":"2011","journal-title":"Pediatrics"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"McGarry, M.E., Raraigh, K.S., Farrell, P., Shropshire, F., Padding, K., White, C., Dorley, M.C., Hicks, S., Ren, C.L., and Tullis, K. (2025). Cystic fibrosis newborn screening: A systematic review-driven consensus guideline from the United States cystic fibrosis foundation. Int. J. Neonatal Screen., 11.","DOI":"10.3390\/ijns11020024"}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/11\/4\/94\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T16:52:21Z","timestamp":1760719941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/11\/4\/94"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijns11040094"],"URL":"https:\/\/doi.org\/10.3390\/ijns11040094","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]}}}